SCHEMBL4127432

SCHEMBL4127432

COc1ccc(CNc2ccc(Cl)cc2C(O)c2ccc(C)cc2OC)c(OC)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APLNR P35414 1/20 0.42
GAA P10253 4/20 0.42
TSHR P16473 4/20 0.42
MAPT P10636 3/20 0.42
TDP1 Q9NUW8 3/20 0.42
ALDH1A1 P00352 3/20 0.42
KDM4E B2RXH2 2/20 0.42
HPGD P15428 1/20 0.42
KDM4C Q9H3R0 2/20 0.41
LMNA P02545 2/20 0.40
MAPK1 P28482 2/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
TAS1R3 Q7RTX0 1/20 0.40
TAS1R1 Q7RTX1 1/20 0.40
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39
HTR2A P28223 1/20 0.39
SLC6A4 P31645 1/20 0.39
KCNH2 Q12809 1/20 0.39
CYP1A2 P05177 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4119617 0.89 TAS1R3 (0.49) APLNRGAATSHRMAPTTDP1
SCHEMBL14146105 0.86 TSHR (0.39) APLNRGAATSHRMAPTTDP1
SCHEMBL4109465 0.85 KDM4C (0.44) APLNRGAATSHRMAPTTDP1
SCHEMBL4116863 0.85 TAS1R3 (0.44) APLNRGAATSHRMAPTTDP1
SCHEMBL8111932 0.84 TAS1R3 (0.47) APLNRGAATSHRMAPTTDP1
SCHEMBL4120083 0.84 TSHR (0.43) APLNRGAATSHRMAPTTDP1
SCHEMBL4122265 0.84 TAS1R3 (0.44) APLNRGAATSHRMAPTTDP1
SCHEMBL4111042 0.83 TSHR (0.42) APLNRGAATSHRMAPTTDP1
SCHEMBL4122733 0.83 TAS1R3 (0.44) APLNRGAATSHRMAPTTDP1
SCHEMBL4121857 0.83 TAS1R3 (0.44) APLNRGAATSHRMAPTTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090181942-A1 TRICYCLIC COMPOUNDS DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-07-16 US disclosed
US-20090181942-A1 TRICYCLIC COMPOUNDS DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-07-16 US disclosed
US-20090181942-A1 TRICYCLIC COMPOUNDS DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-07-16 US disclosed
EP-1939205-A1 TRICYCLIC COMPOUND Daiichi Sankyo Company, Limited (JP) 2008-07-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090181942-A1 TRICYCLIC COMPOUNDS FDFT1, COASY, HMGCR APLNR 795/4885GAA 922/4885TSHR 1672/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.